Pulmonx (LUNG) Competitors $2.59 -0.04 (-1.52%) Closing price 04:00 PM EasternExtended Trading$2.67 +0.08 (+3.24%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUNG vs. AXGN, NPCE, OM, TMCI, SMLR, CLPT, NNOX, CATX, SNWV, and NYXHShould you be buying Pulmonx stock or one of its competitors? The main competitors of Pulmonx include AxoGen (AXGN), NeuroPace (NPCE), Outset Medical (OM), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Perspective Therapeutics (CATX), SANUWAVE Health (SNWV), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry. Pulmonx vs. Its Competitors AxoGen NeuroPace Outset Medical Treace Medical Concepts Semler Scientific ClearPoint Neuro Nano-X Imaging Perspective Therapeutics SANUWAVE Health Nyxoah AxoGen (NASDAQ:AXGN) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Is AXGN or LUNG more profitable? AxoGen has a net margin of -3.68% compared to Pulmonx's net margin of -65.27%. AxoGen's return on equity of -7.09% beat Pulmonx's return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-3.68% -7.09% -3.67% Pulmonx -65.27%-63.69%-34.94% Which has more risk & volatility, AXGN or LUNG? AxoGen has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Pulmonx has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Do institutionals and insiders hold more shares of AXGN or LUNG? 80.3% of AxoGen shares are held by institutional investors. Comparatively, 91.0% of Pulmonx shares are held by institutional investors. 2.8% of AxoGen shares are held by insiders. Comparatively, 6.8% of Pulmonx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts prefer AXGN or LUNG? AxoGen presently has a consensus target price of $22.20, indicating a potential upside of 112.03%. Pulmonx has a consensus target price of $11.53, indicating a potential upside of 344.98%. Given Pulmonx's higher possible upside, analysts plainly believe Pulmonx is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Pulmonx 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63 Which has better earnings & valuation, AXGN or LUNG? AxoGen has higher revenue and earnings than Pulmonx. AxoGen is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$187.34M2.55-$9.96M-$0.15-69.80Pulmonx$83.79M1.24-$56.39M-$1.44-1.80 Does the media prefer AXGN or LUNG? In the previous week, AxoGen had 2 more articles in the media than Pulmonx. MarketBeat recorded 3 mentions for AxoGen and 1 mentions for Pulmonx. Pulmonx's average media sentiment score of 1.87 beat AxoGen's score of 1.65 indicating that Pulmonx is being referred to more favorably in the news media. Company Overall Sentiment AxoGen Very Positive Pulmonx Very Positive SummaryAxoGen beats Pulmonx on 10 of the 15 factors compared between the two stocks. Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUNG vs. The Competition Export to ExcelMetricPulmonxMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$104.27M$2.01B$5.43B$8.84BDividend YieldN/AN/A5.37%4.21%P/E Ratio-1.8035.6525.6219.59Price / Sales1.2416.24374.24100.07Price / CashN/A55.3536.0056.49Price / Book1.199.327.865.50Net Income-$56.39M-$62.55M$3.15B$248.79M7 Day Performance-5.82%0.71%1.27%2.15%1 Month Performance-16.72%9.15%5.50%5.82%1 Year Performance-57.82%2.96%39.41%18.22% Pulmonx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUNGPulmonx3.684 of 5 stars$2.59-1.5%$11.53+345.0%-56.5%$104.27M$83.79M-1.80250Positive NewsAXGNAxoGen2.6761 of 5 stars$9.75flat$22.20+127.7%+40.8%$444.05M$194.52M-30.47450Positive NewsNPCENeuroPace3.7759 of 5 stars$11.09+0.2%$15.50+39.8%+57.5%$363.74M$84.31M-11.09170OMOutset Medical1.9933 of 5 stars$20.46+2.5%$27.00+32.0%-70.0%$362.59M$115.27M-8.25520High Trading VolumeTMCITreace Medical Concepts2.197 of 5 stars$5.76+1.6%$10.16+76.3%+1.0%$362.25M$210.82M-5.82250SMLRSemler Scientific2.2348 of 5 stars$30.52+3.2%$71.00+132.6%+12.5%$340.36M$49.23M6.22120CLPTClearPoint Neuro2.9723 of 5 stars$11.60+0.5%$25.00+115.5%+110.4%$324.67M$32.24M-16.81110Gap UpNNOXNano-X Imaging2.1438 of 5 stars$5.26+4.4%$9.50+80.6%-19.5%$303.92M$11.55M-6.19190CATXPerspective Therapeutics3.589 of 5 stars$3.61+13.9%$12.63+249.7%-60.1%$267.96M$1.43M0.0070Analyst ForecastAnalyst RevisionGap UpSNWVSANUWAVE HealthN/A$30.95+4.2%N/AN/A$264.81M$36.19M-6.7940Positive NewsNYXHNyxoah2.5185 of 5 stars$7.75+2.8%$14.50+87.1%-2.0%$263.97M$4.36M-4.14110Gap Up Related Companies and Tools Related Companies AxoGen Competitors NeuroPace Competitors Outset Medical Competitors Treace Medical Concepts Competitors Semler Scientific Competitors ClearPoint Neuro Competitors Nano-X Imaging Competitors Perspective Therapeutics Competitors SANUWAVE Health Competitors Nyxoah Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUNG) was last updated on 6/26/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy July is critical for your stocksBig Study Shows Stocks Extremely Likely to Crash in 2026? Legendary quant analyst Marc Chaikin says in 50 y...Chaikin Analytics | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
